CLINICAL RESEARCH

$157,506P30FY2002CANIH

Sloan-Kettering Institute For Cancer Res, New York NY

Investigators

Linked publications & trials

Paper 39739622 Paper 39738196 Paper 39737413 Paper 39726772 Paper 39725745 Paper 39719512 Paper 39715901 Paper 39715484 Paper 39711552 Paper 39711539 Paper 39711206 Paper 39711135 Paper 39707616 Paper 39699236 Paper 39695225 Paper 39681721 Paper 39678127 Paper 39677721 Paper 39671171 Paper 39660045 Paper 39658684 Paper 39657258 Paper 39656390 Paper 39655835 Paper 39648687 Paper 39644064 Paper 39644055 Paper 39643732 Paper 39642329 Paper 39638993 Paper 39636079 Paper 39630912 Paper 39629931 Paper 39627554 Paper 39617530 Paper 39610659 Paper 39607536 Paper 39605729 Paper 39605608 Paper 39605552 Paper 39605530 Paper 39605503 Paper 39605444 Paper 39605368 Paper 39605320 Paper 39605035 Paper 39604747 Paper 39589616 Paper 39589333 Paper 39584538 Paper 39579222 Paper 39576455 Paper 39576446 Paper 39575119 Paper 39575113 Paper 39570652 Paper 39570297 Paper 39567740 Paper 39567689 Paper 39562780 Paper 39556172 Paper 39551602 Paper 39548864 Paper 39548022 Paper 39539260 Paper 39536799 Paper 39533260 Paper 39532885 Paper 39532065 Paper 39524528 Paper 39514841 Paper 39513941 Paper 39511421 Paper 39510072 Paper 39509846 Paper 39508931 Paper 39508482 Paper 39506116 Paper 39505858 Paper 39502445 Paper 39499902 Paper 39498218 Paper 39491719 Paper 39489814 Paper 39484591 Paper 39484455 Paper 39482298 Paper 39481074 Paper 39480534 Paper 39478232 Paper 39475167 Paper 39471810 Paper 39470729 Paper 39468367 Paper 39468290 Paper 39467396 Paper 39464104 Paper 39464061 Paper 39463937 Paper 39462976

Abstract

Description: The Clinical Research Program provides a coordinated focus for interdisciplinary, interdepartmental and interprogrammatic clinical research activities at MSKCC. It is organized into disease-oriented projects and treatment modality-related projects. The disease-oriented projects are programmatically linked with comprehensive Disease Management Teams. A Disease Management System has been implemented that includes 17 multidisciplinary teams, which allows for standardization of care, the collection of outcomes data, the capture of cost data, and the integration and refinement of the clinical research effort. The Disease Management System helps to prioritize and define the disease-specific research agenda of the Clinical Research Program. Though 65 project leaders are listed in the application, over 200 researchers and research fellows participate in this program. Disease-oriented projects include diagnostic and therapeutic activities in Brain Tumors, Breast Cancer, Gastrointestinal Cancer, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Cancer, Hepatobiliary Cancer, Leukemia, Lymphoma, Melanoma, Multiple Myeloma, Musculoskeletal Cancers, Pediatric Oncology, Soft Tissue Sarcoma, and Thoracic Malignancies. Modality-related projects are organized in Conformal Radiation, Cytokines, Medical Imaging, Developmental Chemotherapy, Monoclonal Antibody Therapy and Cancer Vaccines, and Transplantation. There are many interactions among projects and programs. In 1995, there were 7212 new patients seen at MSKCC and 1959 accruals to protocols. A total of 59 new patients were placed on national protocols and 1084 patients on local studies. A total of 33 previously treated patients were placed on national studies and 783 patients on local studies. All of the core facilities play a fundamental role in the studies carried out within the Clinical Research Program and are essential to the ongoing research, especially Biostatistics for study design and data analysis. Funded peer-reviewed projects include 11 P01 grants, 8 U01 grants and a large number of R01 grants. In addition, there are 18 training grants and career development awards associated with the Clinical Research Program. External peer reviewed funding for research projects exceeded $18 million.

View original record on NIH RePORTER →